URINARY BLADDER NEOPLASMS
Clinical trials for URINARY BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer combo therapy trial halted early
Disease control TerminatedThis study tested whether adding the immunotherapy drug nivolumab to standard BCG treatment could help people with high-risk bladder cancer that returned after BCG therapy. The trial aimed to see if the combination delayed cancer recurrence or progression better than BCG alone. O…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New bladder cancer drug put to the test in early study
Disease control TerminatedThis study tested a drug called enfortumab vedotin for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug was placed directly into the bladder using a thin tube. The main goals were to check for side effects and see how the body handles the dr…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Experimental bladder cancer drug combo shows promise but study halted early
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and to monitor side effects. The study included 348 participants b…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 06:47 UTC